Zai Lab Limited (ZLAB) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

16/25

Growth 5 Margin 2 Expansion 5 Platform 1 Financial 3

latest quarter score

Earnings Reports

16
ZLAB Q2 2026: 11% Sequential Product Revenue Lift Anchors Global Pipeline Acceleration
August 06, 2026
10
ZLAB Q1 2026: Product Revenue Falls 6% as Pipeline Execution Outpaces Near-Term Commercial Growth
May 07, 2026
15
ZLAB Q4 2025: Pipeline Drives 17% Revenue Growth, Sets Stage for 2026 Launches
February 26, 2026
11
ZLAB Q3 2025: R&D Expenses Down 27% as Global Pipeline Accelerates Toward 2027 Inflection
November 06, 2025
14
ZLAB Q2 2025: Operating Loss Narrows 28% as Pipeline Advancements Drive Profitability Path
August 07, 2025
21
Zai Lab (ZLAB) Q1 2025: SG&A Down 8% as Profitability Path Sharpens
July 07, 2025

Browse all companies